HOUSTON--(BUSINESS WIRE)--Aug. 24, 2006--CytoGenix, Inc. (OTCBB:CYGX) announced today that it has filed a patent application entitled "Single Stranded Expression Systems for Cancer Genetics and Other Applications" with the US Patent and Trademark Office.
